Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Kelyniam Global Inc (ID) KLYG

Healthcare Technology Medical Devices Scientific & Technical Instruments
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction... see more

Recent & Breaking News ()

Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP® Fusion Biomaterial in Cranial Implants

GlobeNewswire November 13, 2025

Kelyniam Global Announces Q3 2025 Financial Results

PR Newswire November 10, 2025

Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products

GlobeNewswire November 6, 2025

Kelyniam Global, Inc. Receives FDA Clearance for Innovative Fusion(TM) BCP-PEEK Implant

PR Newswire September 18, 2025

Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th

PR Newswire September 15, 2025

Commitment to Investor

PR Newswire September 8, 2025

Kelyniam Global Announces Q2 2025 Financial Results

PR Newswire August 11, 2025

Kelyniam Global Announces Q1 2025 Financial Results and Strategic Partnership

PR Newswire May 12, 2025

KELYNIAM ACHIEVES RECORD REVENUE & PROFITABILITY FOR 2024

PR Newswire March 17, 2025

Kelyniam Corporate Update

PR Newswire January 21, 2025

Kelyniam Global, Inc., ("KLYG") Announces Private Investment to Public Entity ("PIPE") Closure of Securities Offering

PR Newswire December 16, 2024

Kelyniam Global Releases Q3 Financials, Strong Performance Continues

PR Newswire November 11, 2024

Kelyniam Global Releases Strong Q2 Financials

PR Newswire August 12, 2024

Kelyniam Global Releases Q1 Financials

PR Newswire May 13, 2024

NEOS Cranial LOOP(TM) Receives FDA Clearance for CustomizedBone(TM) Use

PR Newswire April 2, 2024

Strong Fourth Quarter Powers 2023 Kelyniam Financials

PR Newswire March 17, 2024

Kelyniam Global Releases 3rd Quarter 2023 Financials

PR Newswire December 21, 2023

Kelyniam Global Releases 2nd Quarter 2023 Financials

PR Newswire August 14, 2023

Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products

PR Newswire May 22, 2023

Kelyniam Global Announces Record Sales of $3 million in 2022 Financial Statements

PR Newswire March 16, 2023

Podcasts